Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|March 28, 2026
Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast CancerBrendah K Masisi, Rokaya El Ansari, Ali Fakroun, et al.
Histopathology|October 10, 2019
The role of glutaminase in cancerBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Breast Cancer Research and Treatment|March 23, 2020
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancerRokaya El Ansari, Lutfi Alfarsi, Madeleine L Craze, et al.
BMC Cancer|May 16, 2020
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancerLutfi H Alfarsi, Rokaya El Ansari, Madeleine L Craze, et al.
Breast Cancer Research and Treatment|July 20, 2021
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancerLutfi H Alfarsi, Rokaya El Ansari, Madeleine L Craze, et al.
Cancer Biology & Therapy|December 11, 2023
The amino acid transporter SLC7A11 expression in breast cancerPreyanka Nath, Lutfi H Alfarsi, Rokaya El-Ansari, et al.
International Journal of Molecular Sciences|February 26, 2020
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast CancerLutfi H Alfarsi, Rokaya El-Ansari, Madeleine L Craze, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 11, 2024
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast CancerRoshni Patel, Lutfi H Alfarsi, Rokaya El-Ansari, et al.
Pageof 2